{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:07:51Z","timestamp":1758053271045,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.crad.2017.12.019","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T20:07:15Z","timestamp":1517602035000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility of a streamlined imaging protocol in technetium-99m-Tektrotyd somatostatin receptor SPECT\/CT"],"prefix":"10.1016","volume":"73","author":[{"given":"H.","family":"Al-Chalabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.","family":"Scarsbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2017.12.019_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2017.12.019_bib2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2014.60.2532","article-title":"Carcinoid and neuroendocrine tumors: building on success","volume":"33","author":"Kunz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2017.12.019_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.critrevonc.2009.02.009","article-title":"Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results","volume":"71","author":"Koopmans","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.crad.2017.12.019_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.crad.2012.03.019","article-title":"Contemporary nuclear medicine imaging of neuroendocrine tumours","volume":"67","author":"Wong","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2017.12.019_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RLU.0b013e3181feedc0","article-title":"Comparison of single time-point [111-In] pentetreotide SPECT\/CT with dual time-point imaging of neuroendocrine tumors","volume":"36","author":"Wong","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2017.12.019_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.crad.2016.02.023","article-title":"PET-CT in the UK: current status and future directions","volume":"71","author":"Scarsbrook","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2017.12.019_bib7","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s002590000289","article-title":"99mTc-EDDA\/HYNIC-TOC: a new (99m)Tc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives","volume":"27","author":"Decristoforo","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.crad.2017.12.019_bib8","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2967\/jnumed.111.088203","article-title":"Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors","volume":"52","author":"Grimes","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2017.12.019_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2017.12.019_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2967\/jnumed.115.161117","article-title":"Significance of a single-time-point somatostatin receptor SPECT\/multiphase CT protocol in the diagnostic work-up of gastroenteropancreatic neuroendocrine neoplasms","volume":"57","author":"Ruf","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2017.12.019_bib11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00259-010-1473-6","article-title":"111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging","volume":"37","author":"Bombardieri","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2017.12.019_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2967\/jnmt.111.098277","article-title":"The SNM practice guideline for somatostatin receptor scintigraphy 2.0","volume":"39","author":"Balon","year":"2011","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.crad.2017.12.019_bib13","first-page":"237","article-title":"99mTc-EDDA\/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors","volume":"49","author":"Gabriel","year":"2005","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2017.12.019_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5603\/NMR.2016.0019","article-title":"Limitations and pitfalls of 99mTc-EDDA\/HYNIC-TOC (Tektrotyd) scintigraphy","volume":"19","author":"Garai","year":"2016","journal-title":"Nucl Med Rev"},{"key":"10.1016\/j.crad.2017.12.019_bib15","first-page":"4","article-title":"Summary of product characteristics","author":"Pharmaka","year":"2016","journal-title":"Tektrotyd HYNIC-[d-Phe1, Tyr3-octreotide] TFA Salt"},{"key":"10.1016\/j.crad.2017.12.019_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNM.0000000000000672","article-title":"A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK","volume":"38","author":"Iball","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.crad.2017.12.019_bib17","first-page":"708","article-title":"An intrapatient comparison of 99mTc-EDDA\/diagnosis of somatostatin receptor-expressing tumors","volume":"44","author":"Gabriel","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2017.12.019_bib18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00259-005-1875-z","article-title":"Image fusion analysis of 99mTc-HYNIC-Tyr3-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours","volume":"32","author":"Gabriel","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2017.12.019_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5603\/NMR.2016.0020","article-title":"Evaluation of neuroendocrine tumors with 99mTc-EDDA\/HYNIC TOC","volume":"19","author":"Artiko","year":"2016","journal-title":"Nucl Med Rev"},{"key":"10.1016\/j.crad.2017.12.019_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/RLU.0000000000001431","article-title":"Physiological uptake in the pancreatic head on somatostatin receptor scintigraphy using [111In-DTPA]octreotide: incidence and mechanism","volume":"42","author":"Brabander","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2017.12.019_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/MNM.0000000000000710","article-title":"Uptake in the pancreatic uncinate process on the 111In-octreotide scintigraphy","volume":"38","author":"Ait Boudaoud","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.crad.2017.12.019_bib22","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00259-013-2482-z","article-title":"Somatostatin receptor PET\/CT in neuroendocrine tumours: update on systematic review and meta-analysis","volume":"40","author":"Geijer","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018300084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018300084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:37:10Z","timestamp":1757867830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926018300084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0009926018300084"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2017.12.019","relation":{},"ISSN":["0009-9260"],"issn-type":[{"type":"print","value":"0009-9260"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of a streamlined imaging protocol in technetium-99m-Tektrotyd somatostatin receptor SPECT\/CT","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2017.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}